Your browser doesn't support javascript.
loading
The HILUS-Trial-a Prospective Nordic Multicenter Phase 2 Study of Ultracentral Lung Tumors Treated With Stereotactic Body Radiotherapy.
Lindberg, Karin; Grozman, Vitali; Karlsson, Kristin; Lindberg, Sara; Lax, Ingmar; Wersäll, Peter; Persson, Gitte Fredberg; Josipovic, Mirjana; Khalil, Azza Ahmed; Moeller, Ditte Sloth; Nyman, Jan; Drugge, Ninni; Bergström, Per; Olofsson, Jörgen; Rogg, Lotte Victoria; Ramberg, Christina; Kristiansen, Charlotte; Jeppesen, Stefan Starup; Nielsen, Tine Bjørn; Lödén, Britta; Rosenbrand, Hans-Olov; Engelholm, Silke; Haraldsson, André; Billiet, Charlotte; Lewensohn, Rolf.
Afiliação
  • Lindberg K; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden; Theme Cancer, Section of Head, Neck, Lung and Skin Tumours, Karolinska University Hospital, Stockholm, Sweden. Electronic address: karin.lindberg@ki.se.
  • Grozman V; Section of Thoracic Radiology, Department of Imaging and Physiology, Karolinska University Hospital, Stockholm, Sweden; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
  • Karlsson K; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden; Section of Radiotherapy Physics and Engineering, Department of Medical Radiation Physics and Nuclear Medicine, Karolinska University Hospital, Stockholm, Sweden.
  • Lindberg S; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden; Theme Cancer, Section of Head, Neck, Lung and Skin Tumours, Karolinska University Hospital, Stockholm, Sweden.
  • Lax I; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden; Section of Radiotherapy Physics and Engineering, Department of Medical Radiation Physics and Nuclear Medicine, Karolinska University Hospital, Stockholm, Sweden.
  • Wersäll P; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden; Section of Radiotherapy, Department of Cancer, Karolinska University Hospital, Stockholm, Sweden.
  • Persson GF; Section of Radiotherapy, Department of Oncology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark; Department of Oncology, Herlev-Gentofte Hospital, University of Copenhagen, Herlev, Denmark; Department of Clinical Medicine, Faculty of Medical Sciences, University of Copenhagen, Copenha
  • Josipovic M; Section of Radiotherapy, Department of Oncology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
  • Khalil AA; Department of Oncology, Aarhus University Hospital, Aarhus, Denmark.
  • Moeller DS; Department of Oncology, Aarhus University Hospital, Aarhus, Denmark.
  • Nyman J; Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; Department of Oncology, Sahlgrenska University Hospital, Gothenburg, Sweden.
  • Drugge N; Department of Therapeutic Radiation Physics, Sahlgrenska University Hospital, Gothenburg, Sweden.
  • Bergström P; Department of Oncology, Northern Sweden University Hospital, Umeå, Sweden.
  • Olofsson J; Department of Oncology, Northern Sweden University Hospital, Umeå, Sweden.
  • Rogg LV; Department of Oncology, Oslo University Hospital, Oslo, Norway.
  • Ramberg C; Department of Medical Physics, Oslo University Hospital, Oslo, Norway.
  • Kristiansen C; Department of Oncology, Vejle Hospital, University Hospital of Southern Denmark, Vejle, Denmark.
  • Jeppesen SS; Department of Oncology, Odense University Hospital, Odense C, Denmark; Institute of Clinical Research, University of Southern Denmark, Odense C, Denmark.
  • Nielsen TB; Laboratory of Radiation Physics, Odense University Hospital, Odense C, Denmark.
  • Lödén B; Oncology department, Central Hospital in Karlstad, Karlstad, Sweden.
  • Rosenbrand HO; Oncology department, Central Hospital in Karlstad, Karlstad, Sweden.
  • Engelholm S; Department of Hematology, Oncology and Radiation Physics, Skåne University Hospital, Lund, Sweden.
  • Haraldsson A; Department of Hematology, Oncology and Radiation Physics, Skåne University Hospital, Lund, Sweden.
  • Billiet C; Department of Radiation Oncology, Iridium Kankernetwerk, Wilrijk (Antwerp), Belgium; Faculty of Medicine and Health Sciences, University of Antwerp, Wilrijk-Antwerp, Belgium.
  • Lewensohn R; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden; Theme Cancer, Section of Head, Neck, Lung and Skin Tumours, Karolinska University Hospital, Stockholm, Sweden.
J Thorac Oncol ; 16(7): 1200-1210, 2021 07.
Article em En | MEDLINE | ID: mdl-33823286
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article